SENSEX NIFTY

Glaxosmithkline

Mar 03, 2015 at 10:45 | Source: PTI
"GlaxoSmithKline (GSK) and Sun Pharmaceutical Industries on Tuesday announced that their respective wholly owned subsidiaries have reached an agreement related to GSK's Opiates business in Australia," the companies said in a joint statement.
Mar 03, 2015 at 09:00 | Source: CNBC-TV18
The transaction is expected to close by August 2015.
Mar 03, 2015 at 08:27 | Source: Moneycontrol.com
GlaxoSmithKline (GSK) and Sun Pharmaceutical Industries today announced that their respective wholly owned subsidiaries have reached an agreement related to GSKs Opiates business in Australia.
Feb 18, 2015 at 13:54 | Source: Moneycontrol.com
Shares of Lupin gained 1.6 percent intraday Wednesday on signing joint venture agreement with Poland-based Celon Pharma for generic asthma drug.
Feb 17, 2015 at 15:35 | Source: PTI
Lupin and Celon Pharma SA have entered into a definitive agreement under which the companies will jointly develop fluticasone/salmeterol dry powder inhaler (DPI) product which is a generic version of GlaxoSmithKline's Advair Diskus, the Mumbai-based firm said in a statement.
Feb 13, 2015 at 08:30 | Source: CNBC-TV18
SBI | M&M | Lupin | BHEL | Coal India | ICICI Bank | Sun Pharma | Cipla | Suzlon Energy | Tata Steel | Ahluwalia Contract | NRB Bearing | Sunil Hitech | Trident | Jayaswal Neco | Amtek Auto | Claris Life | SpiceJet | Gitanjali Gems | Mangalore Chemicals | Gillette India | Future Retail and Titan are stocks, which are in the news today.
Feb 12, 2015 at 20:56 | Source: PTI
"Pursuant to the global deal, the company will have its distribution rights terminated for the oncology portfolio in return for accessing the distribution rights of the acquired vaccines portfolio," GlaxoSmithKline Pharmaceuticals Ltd said in a filing to the BSE.
Feb 12, 2015 at 14:13 | Source: Moneycontrol.com
Its EBITDA was flat at Rs 115 crore versus Rs 118 crore.
Feb 11, 2015 at 15:53 | Source: Moneycontrol.com
Emkay has come out with its 11 stock picks report. The research firm has recommended to buy Jagran Prakashan, PVR, UPL, GSK Consumer; accumulate Shoppers Stop; reduce Divis Laboratories, Thermax; hold Exide Industries, NHPC and sell Punjab National Bank, JSW Energy in its research report dated February 4, 2015.
Feb 09, 2015 at 14:20 | Source: Moneycontrol.com
Sharekhan has recommended a hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 6,005 per share in its research report dated February 05, 2015.
Messages on Glaxosmithkline »

arinshare

Gold Member

9 Followers

MF Investment Help  

Dear Soporofic, I take fancy of two stocks - GlaxoSmithKline Pharmaceuticals and GlaxoSmithKline Consumer Healthcare. Please share your stand on its future prospects. Another point I like to know how do you buy or pick stock right now at this life time high market? What is your conviction

4.08 PM Jul 6th 2014

Web Messenger

Platinum Member

273561 Followers

GlaxoSmithKline  

Source:BBC - Allegations that pharmaceutical giant GlaxoSmithKline (GSK) systematically bribed doctors in China are credible, says an investigator hired by the firm. Peter Humphrey was hired only to investigate who was behind a suspected smear campaign against GSK. But after he finished his report

3.50 PM Jul 4th 2014

Web Messenger

Platinum Member

273561 Followers

GlaxoSmithKline  

Source:BBC - To observers of China`s contemporary business culture it will come as no great surprise that the latest twist in GlaxoSmithKline`s China crisis is a sex tape. The secret filming of business, political and love rivals in intimate situations is now commonplace in China and motivations

3.50 PM Jul 4th 2014

Expert Chartist

Platinum Member

10701 Followers

GlaxoSmithKline  

At 12:00 hrs GlaxoSmithKline has formed a bearish bar reversal chart pattern today. A Bearish Bar Reversal occurs when today\'s high is higher than its previous day high and the current price / today\'s close is lower than its previous day close.

12.00 PM Jul 4th 2014

Omar_An

Silver Member

0 Follower

GlaxoSmithKline  

USA-based Isis Pharmaceuticals has earned yet another $1 million payment from UK pharma giant GlaxoSmithKline.

11.09 AM Jul 4th 2014

PipaDove

New Member

0 Follower

GlaxoSmithKline  

3000 just round the corner. Buy and wait! - My target for GlaxoSmithKline is Rs 3000 for the short term with a stoploss of Rs 2545

10.42 AM Jul 4th 2014

BSE/NSE Announcer

Platinum Member

6747 Followers

GlaxoSmith Con  

GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that in accordance with the Companys Policy on Insider Trading, the date of commencement of closing of "Trading Window" shall be from July 03, 2014 and shall end 24 hours after public announcement of the Quarterly Financial Result

5.40 PM Jul 2nd 2014

GlaxoSmithKline  

GlaxoSmithKline is a Sell - My target for GlaxoSmithKline is Rs 25120 for the short term with a stoploss of Rs 560

2.47 PM Jun 30th 2014

Market Statistician

Platinum Member

12311 Followers

GlaxoSmithKline  

GlaxoSmithKline Pharmaceuticals has touched a 52-week low of Rs 2,351.60. At 15:13 hrs, the share was quoting at Rs 2,466.00, down Rs 9.55, or 0.39%. See more

3.15 PM Jun 26th 2014

Market Statistician

Platinum Member

12311 Followers

GlaxoSmithKline  

GlaxoSmithKline Pharmaceuticals has touched a 52-week low of Rs 2,351.60. At 13:13 hrs, the share was quoting at Rs 2,460.10, down Rs 15.45, or 0.62%. See more

1.15 PM Jun 26th 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.